{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T12:24:39Z","timestamp":1775132679614,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T00:00:00Z","timestamp":1639612800000},"content-version":"am","delay-in-days":349,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.bbrc.2020.11.123","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T03:57:08Z","timestamp":1608177428000},"page":"47-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["In\u00a0vitro display evolution of IL-6R-binding unnatural peptides ribosomally initiated and cyclized with m-(chloromethyl)benzoic acid"],"prefix":"10.1016","volume":"535","author":[{"given":"Yukio","family":"Takamori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Fuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8506-3750","authenticated-orcid":false,"given":"Takashi","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2020.11.123_bib1","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.immuni.2019.03.026","article-title":"Targeting interleukin-6 signaling in clinic","volume":"50","author":"Kang","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.bbrc.2020.11.123_bib2","doi-asserted-by":"crossref","first-page":"102452","DOI":"10.1016\/j.jaut.2020.102452","article-title":"Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?","volume":"111","author":"Liu","year":"2020","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.bbrc.2020.11.123_bib3","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1136\/annrheumdis-2013-204405","article-title":"Sarilumab, a fully human monoclonal antibody against IL-6R\u03b1 in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomized SARIL-RA-MOBILITY Part A trial","volume":"73","author":"Huizinga","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bbrc.2020.11.123_bib4","first-page":"8","article-title":"Abstract 2723: sarilumab (REGN88), a fully-human anti-IL6R antibody, inhibits tumor growth in preclinical models, as a single agent and in combination with the VEGF blocker aflibercept","volume":"72","author":"Zhang","year":"2012","journal-title":"Canc. Res."},{"key":"10.1016\/j.bbrc.2020.11.123_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2013-eular.2360","article-title":"AB0037 Evaluation of the binding kinetics and functional bioassay activity of sarilumab and tocilizumab to the human il-6 receptor (il-6r) alpha","volume":"72","author":"Rafique","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bbrc.2020.11.123_bib6","doi-asserted-by":"crossref","first-page":"9326","DOI":"10.1074\/jbc.M117.818559","article-title":"A\u00a0bispecific antibody that targets IL-6 receptor and IL-17A for the potential therapy of patients with autoimmune and inflammatory diseases","volume":"293","author":"Lyman","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2020.11.123_bib7","first-page":"6","article-title":"A\u00a0dual target-directed agent against interleukin-6 receptor and tumor necrosis factor \u03b1 ameliorates experimental arthritis","volume":"6","author":"Kim","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2020.11.123_bib8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1756-6606-4-2","article-title":"Directed evolution of a three-finger neurotoxin by using cDNA display yields antagonists as well as agonists of interleukin-6 receptor signaling","volume":"4","author":"Naimuddin","year":"2011","journal-title":"Mol. Brain"},{"key":"10.1016\/j.bbrc.2020.11.123_bib9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13075-015-0651-0","article-title":"The preclinical pharmacology of the high affinity anti-IL-6R Nanobody\u00ae ALX-0061 supports its clinical development in rheumatoid arthritis","volume":"17","author":"Roy","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bbrc.2020.11.123_bib10","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/aps.2014.90","article-title":"Establishment of a novel cell-based assay for screening small molecule antagonists of human interleukin-6 receptor","volume":"35","author":"He","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbrc.2020.11.123_bib11","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1158\/0008-5472.CAN-05-0188","article-title":"A\u00a0novel peptide specifically binding to interleukin-6 receptor (gp80) inhibits angiogenesis and tumor growth","volume":"65","author":"Su","year":"2005","journal-title":"Canc. Res."},{"key":"10.1016\/j.bbrc.2020.11.123_bib24","doi-asserted-by":"crossref","first-page":"12297","DOI":"10.1073\/pnas.94.23.12297","article-title":"RNA-peptide fusions for the in\u00a0vitro selection of peptides and proteins","volume":"94","author":"Roberts","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2020.11.123_bib25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0014-5793(97)01026-0","article-title":"In\u00a0vitro virus: bonding of mRNA bearing puromycin at the 3\u2019-terminal end to the C-terminal end of its encoded protein on the ribosome in\u00a0vitro","volume":"414","author":"Nemoto","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2020.11.123_bib12","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1093\/nar\/gkp514","article-title":"cDNA display: a novel screening method for functional disulfide-rich peptides by solid-phase synthesis and stabilization of mRNA-protein fusions","volume":"37","author":"Yamaguchi","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2020.11.123_bib13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bbrc.2012.03.130","article-title":"Antagonistic effect of disulfide-rich peptide aptamers selected by cDNA display on interleukin-6-dependent cell proliferation","volume":"421","author":"Nemoto","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2020.11.123_bib14","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1021\/acschembio.5b01014","article-title":"Directed evolution of a cyclized peptoid-peptide chimera against a cell-free expressed protein and proteomic profiling of the interacting proteins to create a protein-protein interaction inhibitor","volume":"11","author":"Kawakami","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bbrc.2020.11.123_bib27","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1002\/anie.201400001","article-title":"Genetically encoding photoswitchable click amino acids in Escherichia coli and mammalian cells","volume":"53","author":"Hoppmann","year":"2014","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.bbrc.2020.11.123_bib26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/90802","article-title":"Cell-free translation reconstituted with purified components","volume":"19","author":"Shimizu","year":"2001","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbrc.2020.11.123_bib33","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.chembiol.2015.10.016","article-title":"DIVERSE system: de novo creation of peptide tags for non-enzymatic covalent labeling by in\u00a0vitro evolution for protein imaging inside living cells","volume":"22","author":"Kawakami","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bbrc.2020.11.123_bib34","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.bbrc.2020.11.050","article-title":"In\u00a0vitro display evolution of the PURE system-expressed TNFa-binding unnatural cyclic peptide containing an N-methyl-D-amino acid","volume":"534","author":"Tsukamoto","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2020.11.123_bib35","doi-asserted-by":"crossref","unstructured":"Ando T., Yamamoto M., Yokoyama T., et\u00a0al., In\u00a0vitro selection generates RNA aptamer that antagonizes PCSK9-LDLR interaction and recovers cellular LDL uptake, J. Biosci. Bioeng., doi:10.1016\/j.jbiosc.2020.10.009, In press.","DOI":"10.1016\/j.jbiosc.2020.10.009"},{"key":"10.1016\/j.bbrc.2020.11.123_bib36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bbrc.2020.11.123","article-title":"In\u00a0vitro display evolution of IL-6R-binding unnatural peptides ribosomally initiated and cyclized with m-(chloromethyl)benzoic acid","volume":"535","author":"Tsukamoto","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2020.11.123_bib15","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1039\/C8NJ04255A","article-title":"An I6P7 peptide modified fluorescent probe for bio-imaging","volume":"43","author":"Yao","year":"2019","journal-title":"New J. Chem."},{"key":"10.1016\/j.bbrc.2020.11.123_bib16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1747-0285.2009.00936.x","article-title":"Magnetic resonance imaging of human glioma cells by means of an interleukin-6 receptor-targeted contrast agent","volume":"75","author":"Sturzu","year":"2010","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bbrc.2020.11.123_bib17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00726-015-2060-8","article-title":"SPECT imaging of interleukin-6 receptor in ovarian tumor xenografts with a novel radiotracer of 99mTc-HYNIC-Aca-LSLITRL","volume":"48","author":"Li","year":"2016","journal-title":"Amino Acids"},{"key":"10.1016\/j.bbrc.2020.11.123_bib18","doi-asserted-by":"crossref","first-page":"27162","DOI":"10.1039\/C7RA03208K","article-title":"Overcoming the blood\u2013brain barrier for glioma-targeted therapy based on an interleukin-6 receptor-mediated micelle system","volume":"44","author":"Shi","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.bbrc.2020.11.123_bib19","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.omtm.2020.03.022","article-title":"Ligand-mediated targeting of cytokine interleukin-27 enhances its bioactivity in\u00a0vivo","volume":"17","author":"Figueiredo","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.bbrc.2020.11.123_bib20","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.ymthe.2017.04.023","article-title":"Antitumoral cascade-targeting ligand for IL-6 receptor-mediated gene delivery to glioma","volume":"25","author":"Wang","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbrc.2020.11.123_bib21","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.3390\/ijms21031108","article-title":"Interleukin-27 gene delivery targeting IL-6r\u03b1-expressing cells as a stress response therapy","volume":"21","author":"Neto","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2020.11.123_bib22","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1038\/mtna.2013.70","article-title":"Chlorin e6 Conjugated Interleukin-6 Receptor Aptamers Selectively Kill Target Cells Upon Irradiation","volume":"3","author":"Kruspe","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X20321677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X20321677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:58:02Z","timestamp":1757764682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X20321677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":30,"alternative-id":["S0006291X20321677"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.11.123","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In\u00a0vitro display evolution of IL-6R-binding unnatural peptides ribosomally initiated and cyclized with m-(chloromethyl)benzoic acid","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.11.123","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}